Table 2 Inhibitory activity of GPI-m36.4 on HIV-1 Env-mediated cell–cell fusion

From: Generation of HIV-resistant cells with a single-domain antibody: implications for HIV-1 gene therapy

HIV-1 Env

Subtype

Tropism

Mean % cell fusion ± SD

GPI-FluIgG03

GPI-m36.4

398-F1_F6_20

A

CCR5

108 ± 4

16 ± 5

92RW020

A

CCR5

113 ± 2

0

92UG037.8

A

CCR5

106 ± 4

0

NL4-3

B

CXCR4

105 ± 4

0

SF162

B

CCR5

105 ± 4

0

R3A

B

CCR5

98 ± 3

0

CNE11

B'

R5X4

110 ± 10

0

ZM53M.PB12

C

CCR5

108 ± 7

0

HIV_25710-2.43

C

CCR5

108 ± 5

0

GX11.13

A/E

CCR5

100 ± 6

5 ± 1

CNE8

A/E

CCR5

107 ± 8

11 ± 3

CNE55

A/E

CCR5

107 ± 10

10 ± 3

CH70.1

B/C

R5X4

100 ± 2

0

CH119.10

B/C

CCR5

106 ± 5

0

BJOX002000.03

B/C

CCR5

110 ± 4

0

  1. *The assay was performed in triplicate and repeated three times. Data are expressed as the means ± SD